Advancing Safe Medications for Moms and Babies Act of 2026
Referred to the House Committee on Energy and Commerce.
Email me when HR 8651 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HR 8651. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The Advancing Safe Medications for Moms and Babies Act directs the HHS Secretary to issue new FDA regulations that better protect and include pregnant and lactating women in drug trials. It also creates a $5 million annual education campaign and a research‑prioritization process at the NICHD to study medicines used by these populations. The bill aims to improve maternal and infant health by filling data gaps.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HR 8651
3 free questions a day, no accountSponsors
- Rep. Castor, Kathy [D-FL-14] (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 8651 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 8651 freeOr ask your AI assistant about HR 8651 directly:
Add to Claude, ChatGPT or Cursor